GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...

Tire manufacturer Bridgestone Americas is closing its LaVergne, Tennessee, truck and bus radial tire plant and laying off 700 ...

The pipeline will run for about 213 kilometres to a $7.4 billion polyethylene plant where construction started last September ...

Analysts predict the home care segment to grow at 5 per cent (Y-o-Y/Q-o-Q?), Beauty and Personal Care (BPC) at 3 per cent, and food at 2 per cent. They expect a decline of 31 bps Y-o-Y in Ebitda ...

Singapore President Tharman Shanmugaratnam visited the state-of-the-art Sapigen Biologix vaccine facility in Bhubaneswar ...

The new facility at Stainton, near Barnard Castle, will power the nearby Glaxo Smith Kline factory for 40 years ...

Hyderabad: Vaccine maker Bharat Biotech invested Rs 1,500 crore in setting up what is touted as one of the world's largest ...

Look deep into nature and then you will understand everything better.” The quote from Albert Einstein is generally deployed ...

Learn More Pharmaceutical giant GSK is pushing the boundaries of what generative AI can achieve in healthcare areas like scientific literature review, genomic analysis and drug discovery.

GSK Plc CEO Emma Walmsley talks about buying US cancer biotech IDRx for as much as $1.15 billion, expanding their portfolio in the US, their overall drug pipeline and working with Robert F.